IDT Biologika GmbH is an innovative, privately-held company with more than 90 years of experience in researching, developing, manufacturing and marketing of biologics. IDT operates one of Europe’s premiere integrated biological and pharmaceutical development and manufacturing facilities.
State-of-the-art technology and a commitment to quality
We are a global supplier to the pharmaceutical and biotechnology industry. With decades of experience developing our own products as well as those of pharmaceutical industry third parties, we understand the needs of our customers when it comes to responsiveness, state-of-the-art technology and integrated solutions - all set against the backdrop of a relentless commitment to quality.
The company has experience in technically sophisticated projects, such as innovative biopharmaceuticals and lyophilized compounds. In March 2009 a U.S. subsidiary was established. This enables them to better support customers in the U.S. drug market and to develop closer working relationship with companies in North America.
EMA and FDA approved biopharmaceutical facilities
In the last 20 years IDT Biologika has invested more than € 280million in building state-of-the-art biopharmaceutical facilities. All facilities have been inspected by international regulatory agencies such as EMA and FDA.
IDT Biologika offers customers access to highly integrated development and manufacturing services, including one of the most comprehensive quality control and testing programs in the industry.
3 Business Areas - Pharmaceuticals, Human Vaccines and Animal Health
The company focuses on three core areas - pharmaceuticals, human vaccines and animal health.
For pharmaceutical markets, IDT Biologika specializes in the development and manufacture of sterile liquid drugs, providing fully-integrated services ranging from formulation development and clinical manufacturing through to large-scale production, packaging and quality control.
For vaccines, IDT Biologika offers development services and manufacturing facilities for clinical phase I to III as well as commercial supplies for leading edge viral and bacterial human vaccines, addressing health issues such as tuberculosis, AIDS, malaria and pox.
For veterinary markets, IDT Biologika develops manufactures and markets a comprehensive range of high-quality vaccines and other products for animal health.
Member of the Klocke Group
As a member of the Klocke Group, IDT Biologika stands out in its work for the biopharmaceutical industry because of the breadth of its activities. The Klocke Group is expert in the areas of innovative packaging solutions and contract manufacturing of solid dosage forms and cytotoxics. This is complemented by IDT Biologika's special understanding of pharmaceutical commercialization, in-depth knowledge of the drug registration process and a highly sophisticated approach to quality control.